Advertisement
Logo
Search for

Volume 59, Issue 4, Pages 502-511 (April 2010)


View previous. 12 of 26 View next.

Effects of meal size and composition on incretin, α-cell, and β-cell responses

Josina M. RijkelijkhuizenaCorresponding Author Informationemail address, Kelly McQuarrieb, Cynthia J. Girmanb, Peter P. Steinc, Andrea Marid, Jens J. Holste, Giel Nijpelsaf, Jacqueline M. Dekkera

Received 26 December 2008; accepted 28 July 2009. published online 21 October 2009.

Abstract 

The incretins glucagon-like peptide–1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate postprandial insulin release from the β-cells. We investigated the effects of 3 standardized meals with different caloric and nutritional content in terms of postprandial glucose, insulin, glucagon, and incretin responses. In a randomized crossover study, 18 subjects with type 2 diabetes mellitus and 6 healthy volunteers underwent three 4-hour meal tolerance tests (small carbohydrate [CH]-rich meal, large CH-rich meal, and fat-rich meal). Non–model-based and model-based estimates of β-cell function and incremental areas under the curve of glucose, insulin, C-peptide, glucagon, GLP-1, and GIP were calculated. Mixed models and Friedman tests were used to test for differences in meal responses. The large CH-rich meal and fat-rich meal resulted in a slightly larger insulin response as compared with the small CH-rich meal and led to a slightly shorter period of hyperglycemia, but only in healthy subjects. Model-based insulin secretion estimates did not show pronounced differences between meals. Both in healthy individuals and in those with diabetes, more CH resulted in higher GLP-1 release. In contrast with the other meals, GIP release was still rising 2 hours after the fat-rich meal. The initial glucagon response was stimulated by the large CH-rich meal, whereas the fat-rich meal induced a late glucagon response. Fat preferentially stimulates GIP secretion, whereas CH stimulates GLP-1 secretion. Differences in meal size and composition led to differences in insulin and incretin responses but not to differences in postprandial glucose levels of the well-controlled patients with diabetes.

a EMGO Institute, VU University Medical Center, 1081 BT Amsterdam, The Netherlands

b Department of Epidemiology, Merck & Co., Inc., Clinical and Quantitative Sciences, North Wales, PA (USA)

c Clinical and Quantitative Sciences, Merck & Co., Clinical Research, Inc., Rahway, NJ, USA

d Institute of Biomedical Engineering, National Research Council, Padua, Italy

e Department of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen

f Department of General Practice, VU University Medical Center, Amsterdam, The Netherlands

Corresponding Author InformationCorresponding author. Tel.: +31 20 444 9831; fax: +31 20 444 8181.

PII: S0026-0495(09)00357-6

doi:10.1016/j.metabol.2009.07.039


View previous. 12 of 26 View next.

Advertisement